Edwards Lifesciences Corporation Share Price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.19 USD | +0.48% |
|
-0.55% | +16.43% |
| 12-05 | Sector Update: Health Care Stocks Lower Late Afternoon | MT |
| 12-05 | Bernstein Adjusts Edwards Lifesciences Price Target to $95 From $90, Maintains Market Perform Rating | MT |
| Capitalization | 50.02B 42.99B 40.28B 37.54B 69.34B 4,501B 75.42B 471B 182B 2,126B 188B 184B 7,773B | P/E ratio 2025 * |
37.5x | P/E ratio 2026 * | 32x |
|---|---|---|---|---|---|
| Enterprise value | 46.73B 40.17B 37.63B 35.07B 64.78B 4,205B 70.46B 440B 170B 1,986B 175B 172B 7,262B | EV / Sales 2025 * |
7.75x | EV / Sales 2026 * | 6.89x |
| Free-Float |
89.32% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.48% | ||
| 1 week | -0.55% | ||
| Current month | -0.55% | ||
| 1 month | +4.55% | ||
| 3 months | +6.49% | ||
| 6 months | +11.18% | ||
| Current year | +16.43% |
| 1 week | 83.6 |  | 87.89 |
| 1 month | 82.01 | | 87.89 |
| Current year | 65.94 | | 87.89 |
| 1 year | 65.94 | | 87.89 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 24.07 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 58 | 31/12/2013 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 06/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 61 | 09/02/2015 |
| Director/Board Member | 57 | 10/05/2023 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.46% | 51 M€ | -2.34% | - |
| 2.34% | 26 M€ | +11.73% | - |
| 1.17% | 27 M€ | +1.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.48% | -0.55% | +20.49% | +19.26% | 50.02B | |
| -0.43% | -3.06% | +8.20% | +4.04% | 215B | |
| +1.18% | +0.32% | +4.53% | +116.04% | 204B | |
| -0.39% | -0.23% | -1.68% | -14.74% | 160B | |
| -0.20% | -4.00% | +8.27% | +115.94% | 145B | |
| +1.92% | +1.56% | -15.42% | -11.65% | 56.48B | |
| -1.91% | -5.22% | +3.49% | -3.87% | 41.18B | |
| +3.56% | +6.84% | +5.19% | - | 38.93B | |
| +2.00% | +0.28% | +6.27% | +17.83% | 37.39B | |
| +1.19% | -0.79% | -22.99% | -37.74% | 34.62B | |
| Average | +0.74% | -0.37% | +1.64% | +22.79% | 98.21B | |
| Weighted average by Cap. | +0.37% | -1.09% | +3.62% | +40.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.03B 5.18B 4.86B 4.53B 8.36B 543B 9.09B 56.8B 21.93B 256B 22.63B 22.15B 937B | 6.62B 5.69B 5.33B 4.97B 9.17B 596B 9.98B 62.33B 24.07B 281B 24.84B 24.31B 1,028B |
| Net income | 1.34B 1.15B 1.08B 1.01B 1.86B 121B 2.02B 12.62B 4.87B 56.95B 5.03B 4.92B 208B | 1.57B 1.35B 1.26B 1.18B 2.17B 141B 2.36B 14.75B 5.7B 66.58B 5.88B 5.75B 243B |
| Net Debt | -3.29B -2.83B -2.65B -2.47B -4.56B -296B -4.96B -30.99B -11.97B -140B -12.35B -12.09B -511B | -4.45B -3.83B -3.59B -3.34B -6.17B -401B -6.72B -41.95B -16.2B -189B -16.72B -16.36B -692B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 86.19 $ | +0.48% | 3,461,311 |
| 04/12/25 | 85.78 $ | +2.14% | 3,612,707 |
| 03/12/25 | 83.98 $ | -0.86% | 2,271,443 |
| 02/12/25 | 84.71 $ | -0.66% | 3,339,401 |
| 01/12/25 | 85.27 $ | -1.62% | 2,644,474 |
Delayed Quote Nyse, December 05, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition